Min Han Tan
About Min Han Tan
Min-Han Tan is the Founding CEO and Medical Director with a PhD and MBBS, known for his contributions to multi-cancer screening tests and expertise in liquid biopsy technology.
Min-Han Tan's Title and Role
Min-Han Tan serves as the Founding CEO and Medical Director. His leadership extends to his role in guiding comprehensive research initiatives and overseeing medical advancements in the field of oncology.
Min-Han Tan's Education and Expertise
Min-Han Tan holds both a PhD and an MBBS, showcasing his extensive medical education. His expertise lies significantly in the development of multi-cancer screening tests, liquid biopsy technology, and next-generation sequencing. His academic contributions reflect a profound understanding of these complex fields.
Min-Han Tan's Research Publications
Min-Han Tan has contributed to multiple publications in prestigious journals, including Annals of Oncology, Journal of Clinical Oncology, and the American Association for Cancer Research. These publications highlight his research in oncology and related technological applications.
Min-Han Tan's Conference Presentations
Min-Han Tan has presented his research at prominent conferences, such as the ASCO Annual Meeting and the World Conference on Lung Cancer. These presentations have allowed him to share his findings on early cancer detection and personalized cancer care with the global scientific community.
Min-Han Tan's Contributions to Cancer Research
Min-Han Tan has been pivotal in research focusing on early cancer detection and personalized cancer care. He has collaborated with other researchers on studies involving circulating tumor DNA (ctDNA) and cell-free RNA (cfRNA), contributing significantly to advancements in the field.